We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600660:SSEFuyao Glass Industry Group Co., Ltd. Class A Analysis

Data as of 2026-07-19 - not real-time

CN¥53.88

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Fuyao Glass trades at CNY 53.88, comfortably above its 20‑day SMA (CNY 51.04) and 50‑day SMA (CNY 52.89) but still below the 200‑day SMA (CNY 60.41), signaling short‑term momentum within a longer‑term bearish backdrop. Technicals are mixed: the MACD histogram is positive (0.45) with a bullish signal crossover, while the RSI sits at 58.6, indicating neither overbought nor oversold conditions. Fundamentally, the stock carries a forward PE of 11.4 and a trailing PE of 15.6, coupled with a robust ROE of 23.4% and a generous dividend yield of 3.9%, suggesting solid earnings quality and shareholder returns. However, the DCF‑derived fair value of only CNY 6.0 starkly contrasts with the current price, flagging a significant valuation gap.
The company benefits from strong cash generation (operating cash flow > CNY 10 bn) and a manageable debt‑to‑equity ratio of 54%, but high volatility (≈ 35% over the past 30 days) and a bearish trend direction temper enthusiasm. With stable trading volumes and a low beta (~0.09), market moves are relatively insulated from broader index swings, yet the cyclical nature of the auto‑parts sector and exposure to Chinese regulatory environments remain key considerations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD crossover supporting near‑term upside
  • Price above short‑term SMAs indicating momentum
  • High dividend yield providing downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Price still below 200‑day SMA, suggesting longer‑term weakness
  • Valuation gap between market price and DCF fair value
  • Cyclical exposure to auto‑parts demand in China

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Significant overvaluation relative to intrinsic DCF estimate
  • Sustained bearish trend direction and high volatility
  • Potential headwinds from regulatory tightening and sector cyclicality

Key Metrics & Analysis

Financial Health

Revenue Growth5.10%
Profit Margin19.43%
P/E Ratio15.6
ROE23.41%
ROA9.31%
Debt/Equity53.94
P/B Ratio3.6
Op. Cash FlowCN¥10.4B
Free Cash FlowCN¥918.3M

Technical Analysis

TrendBearish
RSI58.6
SupportCN¥47.53
ResistanceCN¥54.39
MA 20CN¥51.04
MA 50CN¥52.89
MA 200CN¥60.41
MACDBullish
VolumeStable
Fear & Greed Index87.91

Valuation

Fair ValueCN¥6.01
GradeOvervalued
TypeBlend
Dividend Yield3.90%

Risk Assessment

Beta0.09
Volatility34.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.